SEC Form D · filed September 2, 2022
Venatorx Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Martin J. Heidecker · Malvern, PADirectorTimothy J. Haines · Malvern, PADirectorEzra J. Felker · Malvern, PAExecMichael C. Diem · Malvern, PADirectorAnthony J. Meehan · Malvern, PAExecSergei J. Petukhov · Malvern, PADirectorDaniel C. Pevear · Malvern, PAExecTimothy J. Henkel · Malvern, PAExecChristopher J. Burns · Malvern, PAExec · DirectorWyatt Cavalier · Wilmington, DEExec · DirectorIsaac H. Kalish · Great Neck, NYExecKim A. Bertolini · Denver, CODirectorMatthew H. Gould · Great Neck, NYExecAndrew Firman · Dallas, TXDirectorSteven H. Rosenzweig · Great Neck, NYDirectorPromus Equity Partners, LLC · Chicago, ILDirectorBenjamin H. Bolanos · Great Neck, NYExecJeffrey H. Gould · Great Neck, NYExecMatt M. Whelan · Long Island City, NYDirectorDavid M. Langer · Long Island City, NYExec · DirectorJohn Evans Jr · Wesley Chapel, FLDirectorO'Meara Lauren · Franklin, TNExecOrin Wolf · NEW YORK, NYExecArabella FCRE Management, LLC · Alpharetta, GAExecJeff J. Seavey · Houston, TXDirectorJohn Uhlein · New York, NYExecDaniel Malooly · Newark, NJDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗